Clinical Trials Logo

Prostate Carcinoma clinical trials

View clinical trials related to Prostate Carcinoma.

Filter by:

NCT ID: NCT03630354 Completed - Breast Carcinoma Clinical Trials

EXERCISING TOGETHER for Couples Coping With Cancer

Start date: January 18, 2019
Phase: N/A
Study type: Interventional

The Exercising Together trial is a single-blind, parallel group, randomized controlled trial comparing 3 arms: Arm 1 (experimental): Exercising Together where couples perform partnered exercise in a supervised, group setting versus two comparator conditions where survivors and partners perform exercise routines separately in either a supervised group setting (Arm 2) or unsupervised at home (Arm 3). All three arms will train for a 6-month period and then be followed 6 months later. Data will be collected at baseline, 3, 6 and 12 months.

NCT ID: NCT03418025 Completed - Prostate Carcinoma Clinical Trials

Exercising Together During Radiation Treatment

Start date: November 1, 2017
Phase: N/A
Study type: Interventional

This pilot clinical trial studies how well the Exercising Together program works in helping couples cope with radiation treatment for prostate cancer. Treatments for cancer can cause side effects for the patient, such as fatigue, add stress for the spousal caregiver, and put strain on the marital relationship. The Exercising Together program is designed to promote teamwork and emotional intimacy during exercise, which itself can help manage fatigue and stress for the patient and spouse, and may facilitate communication between partners about day-to-day energy, abilities, and motivation.

NCT ID: NCT03406013 Completed - Prostate Carcinoma Clinical Trials

Internet-Based Exercise and Diet Support in Prostate Cancer Survivors

Start date: August 1, 2017
Phase: N/A
Study type: Interventional

This pilot clinical trial studies how well the True NTH Community of Wellness internet-based exercise and diet support works in improving diet and exercise habits in prostate cancer survivors. Internet-based exercise and diet support may help better control treatment-related side effects and symptoms, better overall quality of life, and lower risk factors associated with cancer progression.

NCT ID: NCT03326440 Completed - Prostate Carcinoma Clinical Trials

Virtual Environment Radiotherapy to Improve Patients' Compliance to Radiotherapy (RT) in Prostate Cancer

VERT
Start date: October 8, 2015
Phase: N/A
Study type: Interventional

Purpose of the study 1. To assess whether offering visual information to patients with prostate cancer prior to receiving RT increases the participant's compliance. 2. To assess whether increased compliance translates into reduced side effects from RT (assessed with a quality of life questionnaire). Type of study. This is a randomised control trial which will include 170 patients with the histological diagnosis of prostate cancer in the study arm and 170 patients with the histological diagnosis of prostate cancer in the control/standard arm.

NCT ID: NCT03135782 Completed - Tobacco Use Clinical Trials

Provider Training in Increasing Patient Tobacco Cessation Counseling and Referrals for Patients With Cancer Undergoing Radiation Therapy

Start date: August 1, 2017
Phase: N/A
Study type: Interventional

This pilot clinical trial studies how well provider training works in increasing patient tobacco cessation counseling and referrals for patients with cancer undergoing radiation therapy. Health care provider training in motivational interviewing techniques and utilizing tobacco cessation resources may help doctors understand how health care providers can effectively increase their confidence in talking to patients about tobacco cessation counseling.

NCT ID: NCT03101046 Completed - Chemotherapy Clinical Trials

Treatment of Metastatic Castrate Resistant Prostate Cancer Patients According to Circulating Tumor Cells Kinetic

TACTIK
Start date: November 15, 2018
Phase: Phase 2
Study type: Interventional

This study compares the biological activity of cabazitaxel (6 cycles) to that of docetaxel (6 cycles) in metastatic castrate-resistant prostate cancer (mCRPC) patients with docetaxel resistant mCRPC defined as ≥5 circulating tumor cells (CTCs) / 7.5 mL after 2 cycles of docetaxel. Patients with docetaxel resistant metastatic castration-resistant prostate cancer (mCRPC) based on circulating tumor cell (CTC) enumeration (patients with ≥5 CTCs / 7.5 mL before docetaxel chemotherapy and after 2 cycles of docetaxel) will receive either 6 additional cycles of docetaxel or 6 additional cycles of cabazitaxel after randomisation. A cohort of patients with docetaxel sensitive metastatic castration-resistant prostate cancer (mCRPC) based on circulating tumor cell (CTC) enumeration (patients ≥5 CTCs / 7.5 mL before docetaxel chemotherapy and <5 CTCs / 7.5 mL after 2 cycles of docetaxel) will receive 6 additional cycles of docetaxel.

NCT ID: NCT03013413 Completed - Prostate Carcinoma Clinical Trials

Ultrasound-Based Imaging Using the Aixplorer System in Diagnosing Prostate Cancer in Patients Undergoing Biopsy

Start date: September 2011
Phase: N/A
Study type: Interventional

This clinical trial studies an ultrasound-based imaging procedure called elastography using the Aixplorer system in diagnosing prostate cancer in patients undergoing biopsy. Ultrasound is a non-invasive imaging technique that uses high-frequency sound waves to produce images of internal structures. Elastography uses ultrasound imaging techniques to examine the stiffness or elasticity of a tissue and may enhance the detection of prostate cancer. It is not yet known whether elastography imaging using the Aixplorer system works better than standard ultrasound imaging in detecting prostate cancer.

NCT ID: NCT02991794 Completed - Prostate Carcinoma Clinical Trials

Prostatectomies Using Einstein Vision® 3D

PROSTEVIS
Start date: May 19, 2017
Phase:
Study type: Observational

The aim of the study is collecting clinical data on the learning curve of different surgeons using the EinsteinVision® 3D visualization system in laparoscopic radical prostatectomies.

NCT ID: NCT02957981 Completed - Pancreatic Cancer Clinical Trials

The Genetic Education for Men Trial: Web-Based Education vs. Standard Care

GEM
Start date: October 1, 2018
Phase: N/A
Study type: Interventional

The primary goal of this research is to develop and test a web-based genetic education/counseling intervention. This intervention is designed to educate men from hereditary cancer families about the personal relevance of genetic testing in order to help them make decisions about whether to pursue genetic testing. The investigators will test this intervention against standard care for men from hereditary cancer families. The web-based educational intervention includes all of the information typically covered during genetic counseling. As a result, after completing the education intervention participants can proceed directly to genetic testing if they choose. The investigators will conduct a survey prior to randomization and then follow-up surveys at 1-month and 6-months post-randomization. The primary outcome will be uptake of genetic testing. Secondary outcomes will be completion of genetic counseling and decision satisfaction.

NCT ID: NCT02927899 Completed - Prostate Carcinoma Clinical Trials

Taste Acceptability of Tomato-Soy-Arugula Seed Beverages in Men With Prostate Cancer

Start date: April 15, 2015
Phase: N/A
Study type: Interventional

This study is a sensory analysis of several different formulations of a novel tomato-soy-arugula seed beverage in men with prostate cancer. Eating a diet rich in a variety of fruits and vegetables has been associated with decreased risk of a variety of diseases, including prostate cancer. Mixed vegetable beverages may be useful in prostate cancer survivorship.